Sökning: WFRF:(Okebe Joseph) > Efficacy of single ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04670naa a2200769 4500 | |
001 | oai:DiVA.org:uu-425574 | |
003 | SwePub | |
008 | 201117s2020 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4255742 URI |
024 | 7 | a https://doi.org/10.1093/infdis/jiaa4982 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Stepniewska, Kasia4 aut |
245 | 1 0 | a Efficacy of single dose primaquine with artemisinin combination therapy on P. falciparum gametocytes and transmission :b A WWARN individual patient meta-analysis. |
264 | c 2020-08-11 | |
264 | 1 | b Oxford University Press (OUP),c 2020 |
338 | a electronic2 rdacarrier | |
520 | a BACKGROUND: Since the World Health Organization recommended single low-dose (0.25mg/kg) primaquine (PQ) in combination with artemisinin-based combination therapies (ACTs) in areas of low transmission or artemisinin-resistant P. falciparum, several single-site studies have been conducted to assess its efficacy.METHODS: An individual patient meta-analysis to assess the gametocytocidal and transmission-blocking efficacy of PQ used in combination with different ACTs was conducted. Random effects logistic regression was used to quantify PQ effect on (i) gametocyte carriage in the first two weeks post-treatment; (ii) the probability of infecting at least one mosquito or of a mosquito becoming infected.RESULTS: In 2,574 participants from fourteen studies, PQ reduced PCR-determined gametocyte carriage on days 7 and 14, most apparently in patients presenting with gametocytaemia on day 0 (Odds Ratio (OR)=0.22; 95%CI 0.17-0.28 and OR=0.12; 95%CI 0.08-0.16, respectively). The rate of decline in gametocyte carriage was faster when PQ was combined with artemether-lumefantrine (AL) compared to dihydroartemisinin-piperaquine (DP) (p=0.010 for day 7). Addition of 0.25mg/kg PQ was associated with near complete prevention of transmission to mosquitoes.CONCLUSION: Primaquine's transmission-blocking effects are achieved with 0.25 mg/kg PQ. Gametocyte persistence and infectivity are lower when PQ is combined with AL compared to DP. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi0 (SwePub)303022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Public Health, Global Health, Social Medicine and Epidemiology0 (SwePub)303022 hsv//eng |
653 | a Plasmodium falciparum | |
653 | a Gametocytaemia | |
653 | a Single low dose primaquine | |
700 | 1 | a Humphreys, Georgina S4 aut |
700 | 1 | a Gonçalves, Bronner P4 aut |
700 | 1 | a Craig, Elaine4 aut |
700 | 1 | a Gosling, Roly4 aut |
700 | 1 | a Guerin, Philippe J4 aut |
700 | 1 | a Price, Ric N4 aut |
700 | 1 | a Barnes, Karen I4 aut |
700 | 1 | a Raman, Jaishree4 aut |
700 | 1 | a Smit, Menno R4 aut |
700 | 1 | a D'Alessandro, Umberto4 aut |
700 | 1 | a Stone, Will J R4 aut |
700 | 1 | a Bjorkman, Anders4 aut |
700 | 1 | a Samuels, Aaron M4 aut |
700 | 1 | a Arroyo-Arroyo, Maria I4 aut |
700 | 1 | a Bastiaens, Guido J H4 aut |
700 | 1 | a Brown, Joelle M4 aut |
700 | 1 | a Dicko, Alassane4 aut |
700 | 1 | a El-Sayed, Badria B4 aut |
700 | 1 | a Elzaki, Salah-Eldin G4 aut |
700 | 1 | a Eziefula, Alice C4 aut |
700 | 1 | a Kariuki, Simon4 aut |
700 | 1 | a Kwambai, Titus K4 aut |
700 | 1 | a Maestre, Amanda E4 aut |
700 | 1 | a Mårtensson, Andreas,d 1963-u Uppsala universitet,Internationell barnhälsa och nutrition4 aut0 (Swepub:uu)andma331 |
700 | 1 | a Mosha, Dominic4 aut |
700 | 1 | a Mwaiswelo, Richard O4 aut |
700 | 1 | a Ngasala, Billy E4 aut |
700 | 1 | a Okebe, Joseph4 aut |
700 | 1 | a Roh, Michelle E4 aut |
700 | 1 | a Sawa, Patrick4 aut |
700 | 1 | a Tiono, Alfred B4 aut |
700 | 1 | a Chen, Ingrid4 aut |
700 | 1 | a Drakeley, Chris J4 aut |
700 | 1 | a Bousema, Teun4 aut |
710 | 2 | a Uppsala universitetb Internationell barnhälsa och nutrition4 org |
773 | 0 | t Journal of Infectious Diseasesd : Oxford University Press (OUP)g 225:7, s. 1215-1226q 225:7<1215-1226x 0022-1899x 1537-6613 |
856 | 4 | u https://doi.org/10.1093/infdis/jiaa498y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1501513/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiaa498/33880656/jiaa498.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-425574 |
856 | 4 8 | u https://doi.org/10.1093/infdis/jiaa498 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy